United Therapeutics Corporation Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31)
United Therapeutics Corporation (UTHR) reported Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) of $500.00 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-10-28.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount · last filed 2014-10-28
- United Therapeutics Corporation stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2014-09-30 was $0.00.
| Period end | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 0 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 1 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 3 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 6 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 9 month |
|---|---|---|---|---|---|
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $500.00M 10-Q · filed 2014-10-28 | |||
| 2014-06-30 | $500.00M 10-Q · filed 2014-07-29 | ||||
| 2013-02-28 | $420.00M 10-Q · filed 2013-10-29 | ||||
| 2013-02-04 | $420.00M 10-K · filed 2013-02-26 | ||||
| 2012-06-30 | $100.00M 10-K · filed 2013-02-26 | ||||
| 2011-10-31 | $300.00M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |